While our GSAS analyses did include multivariate Cox proportional hazards models that account for estrogen receptor status and lymph node metastasis in the van de Vijver dataset, we did not stratify patients by molecular subtype of breast cancer when comparing good and poor prognosis groups. The gene discussed is ESR1; the disease is breast carcinoma.